ACER

Acer Therapeutics (ACER)

Acer Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ACER

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/11/09	06:13	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ACER	Acer Therapeutics Inc
2023/11/09	06:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACER	Acer Therapeutics Inc
2023/11/02	21:51	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ACER	Acer Therapeutics Inc
2023/11/02	21:50	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ACER	Acer Therapeutics Inc
2023/11/02	21:49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACER	Acer Therapeutics Inc
2023/11/02	21:30	GlobeNewswire Inc.	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals	NASDAQ:ACER	Acer Therapeutics Inc
2023/10/30	20:24	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ACER	Acer Therapeutics Inc
2023/10/11	06:17	Edgar (US Regulatory)	Form DEFM14A - Definitive proxy statement relating to merger or acquisition	NASDAQ:ACER	Acer Therapeutics Inc
2023/08/31	22:29	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ACER	Acer Therapeutics Inc
2023/08/31	22:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACER	Acer Therapeutics Inc
2023/08/31	20:30	GlobeNewswire Inc.	Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product	NASDAQ:ACER	Acer Therapeutics Inc
2023/08/31	05:05	GlobeNewswire Inc.	Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe	NASDAQ:ACER	Acer Therapeutics Inc
2023/08/15	05:19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACER	Acer Therapeutics Inc
2023/08/15	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACER	Acer Therapeutics Inc
2023/08/15	05:05	GlobeNewswire Inc.	Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:ACER	Acer Therapeutics Inc
2023/06/26	22:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACER	Acer Therapeutics Inc
2023/06/26	21:30	GlobeNewswire Inc.	Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder	NASDAQ:ACER	Acer Therapeutics Inc
2023/06/08	05:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACER	Acer Therapeutics Inc
2023/05/23	05:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACER	Acer Therapeutics Inc
2023/05/16	06:29	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ACER	Acer Therapeutics Inc
2023/05/16	06:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACER	Acer Therapeutics Inc
2023/05/16	06:10	GlobeNewswire Inc.	Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update	NASDAQ:ACER	Acer Therapeutics Inc
2023/05/04	19:00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACER	Acer Therapeutics Inc
2023/05/01	22:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACER	Acer Therapeutics Inc
2023/05/01	21:30	GlobeNewswire Inc.	Acer Therapeutics Announces OLPRUVA™ Commercial Launch Progressing Ahead of Schedule	NASDAQ:ACER	Acer Therapeutics Inc
2023/04/27	19:25	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:ACER	Acer Therapeutics Inc
2023/04/15	05:29	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:ACER	Acer Therapeutics Inc
2023/03/28	05:18	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ACER	Acer Therapeutics Inc
2023/03/28	05:13	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ACER	Acer Therapeutics Inc
2023/03/28	05:01	GlobeNewswire Inc.	Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update	NASDAQ:ACER	Acer Therapeutics Inc